Cargando…

Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis

Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges i...

Descripción completa

Detalles Bibliográficos
Autores principales: Arumugam, Sivasenthil, Woolley, Katherine, Smith, Ryan A, Vellanky, Smitha, Cremins, Michael S, Dulipsingh, Latha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540179/
https://www.ncbi.nlm.nih.gov/pubmed/33047085
http://dx.doi.org/10.7759/cureus.10295
_version_ 1783591152545431552
author Arumugam, Sivasenthil
Woolley, Katherine
Smith, Ryan A
Vellanky, Smitha
Cremins, Michael S
Dulipsingh, Latha
author_facet Arumugam, Sivasenthil
Woolley, Katherine
Smith, Ryan A
Vellanky, Smitha
Cremins, Michael S
Dulipsingh, Latha
author_sort Arumugam, Sivasenthil
collection PubMed
description Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges in maintaining acceptable blood glucose levels in patients with diabetes. Objective Compare two doses of dexamethasone (4mg and 8mg) for outcomes in patients undergoing hip and knee arthroplasty. Methods Medical records of 3,194 patients having undergone total hip arthroplasty (THA) and total knee arthroplasty (TKA) between January 1, 2016 and December 31, 2017 who were administered dexamethasone were reviewed. The eligible population included male and female patients aged 18-89, who underwent elective hip and knee replacement surgery and were administered dexamethasone intraoperatively. Demographics, clinical variables, and preoperative diabetic status were recorded. Primary outcomes included: blood glucose levels, incidence of PONV, post-anesthesia care unit (PACU) time, and length of stay (LOS). Postoperative complications such as periprosthetic joint injection and urinary tract infections (UTI) were also examined within 90 days of surgery. The 30-day readmissions rate was also collected for analysis. Results There was no PONV in the entire patient population. There were no significant differences between 4mg and 8mg dexamethasone in patients with or without diabetes, for preop to postop blood glucose difference, surgical timing, and post-operative complications. Conclusion Dexamethasone in both 4mg and 8mg dose was effective in PONV prophylaxis. The effects of 4mg and 8mg dexamethasone were the same in individuals with and without diabetes and the increases in blood glucose were not significantly different. Dexamethasone should not be withheld, as its benefits seem to outweigh the risks even in patients with diabetes.
format Online
Article
Text
id pubmed-7540179
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75401792020-10-11 Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis Arumugam, Sivasenthil Woolley, Katherine Smith, Ryan A Vellanky, Smitha Cremins, Michael S Dulipsingh, Latha Cureus Anesthesiology Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges in maintaining acceptable blood glucose levels in patients with diabetes. Objective Compare two doses of dexamethasone (4mg and 8mg) for outcomes in patients undergoing hip and knee arthroplasty. Methods Medical records of 3,194 patients having undergone total hip arthroplasty (THA) and total knee arthroplasty (TKA) between January 1, 2016 and December 31, 2017 who were administered dexamethasone were reviewed. The eligible population included male and female patients aged 18-89, who underwent elective hip and knee replacement surgery and were administered dexamethasone intraoperatively. Demographics, clinical variables, and preoperative diabetic status were recorded. Primary outcomes included: blood glucose levels, incidence of PONV, post-anesthesia care unit (PACU) time, and length of stay (LOS). Postoperative complications such as periprosthetic joint injection and urinary tract infections (UTI) were also examined within 90 days of surgery. The 30-day readmissions rate was also collected for analysis. Results There was no PONV in the entire patient population. There were no significant differences between 4mg and 8mg dexamethasone in patients with or without diabetes, for preop to postop blood glucose difference, surgical timing, and post-operative complications. Conclusion Dexamethasone in both 4mg and 8mg dose was effective in PONV prophylaxis. The effects of 4mg and 8mg dexamethasone were the same in individuals with and without diabetes and the increases in blood glucose were not significantly different. Dexamethasone should not be withheld, as its benefits seem to outweigh the risks even in patients with diabetes. Cureus 2020-09-07 /pmc/articles/PMC7540179/ /pubmed/33047085 http://dx.doi.org/10.7759/cureus.10295 Text en Copyright © 2020, Arumugam et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Anesthesiology
Arumugam, Sivasenthil
Woolley, Katherine
Smith, Ryan A
Vellanky, Smitha
Cremins, Michael S
Dulipsingh, Latha
Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title_full Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title_fullStr Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title_full_unstemmed Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title_short Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
title_sort comparison of dexamethasone 4mg vs 8mg doses in total joint arthroplasty patients: a retrospective analysis
topic Anesthesiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540179/
https://www.ncbi.nlm.nih.gov/pubmed/33047085
http://dx.doi.org/10.7759/cureus.10295
work_keys_str_mv AT arumugamsivasenthil comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis
AT woolleykatherine comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis
AT smithryana comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis
AT vellankysmitha comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis
AT creminsmichaels comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis
AT dulipsinghlatha comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis